Phathom Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:PHAT) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 387.04 M378.32 M294.21 M250.22 M240.29 M259.15 M Total liabilities 574.16 M631.9 M632.58 M656.05 M662.82 M697.32 M Total equity 187.11 M253.58 M338.38 M405.83 M422.53 M438.17 M Total liabilities & shareholders' equities 387.04 M378.32 M294.21 M250.22 M240.29 M259.15 M Total debt —————— Net debt ——————

新闻

古根海姆上调Phathom股票目标价至25美元,因营收超预期

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel重申Phathom股票买入评级,维持28美元目标价

Stifel reiterates Buy on Phathom stock, keeps $28 price target

Phathom 2025年第四季度业绩:营收增长217%,盈利在望

Phathom Q4 2025 slides: 217% revenue growth, profitability in sight

Phathom PharmaQ4每股收益及营收超出预期

Phathom Pharma earnings beat by $0.34, revenue topped estimates

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals stock maintains Buy rating at Stifel on strong revenue outlook

Cantor Fitzgerald维持Phathom股票"增持"评级，目标价29美元

Cantor Fitzgerald reiterates Overweight rating on Phathom stock at $29